IC
MRTX

IEQ Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

IEQ Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,615
Closed -$741K – 1013
2023
Q4 		$741K Hold
12,615
– – 0.01% 485
2023
Q3 		$550K Sell
12,615
-8
-0.1% -$286 0.01% 543
2023
Q2 		$456K Buy
12,623
+8
+0.1% +$330 0.01% 568
2023
Q1 		$469K Hold
12,615
– – 0.01% 589
2022
Q4 		$572K Sell
12,615
-6
-0% -$388 0.02% 481
2022
Q3 		$881K Buy
12,621
+6
+0% +$444 0.02% 395
2022
Q2 		$847K Sell
12,615
-9
-0.1% -$572 0.03% 339
2022
Q1 		$1.04M Buy
12,624
+9
+0.1% +$920 0.02% 323
2021
Q4 		$1.85M Sell
12,615
-234
-2% -$36.3K 0.04% 210
2021
Q3 		$2.27M Buy
+12,849
New +$2.07M 0.06% 166

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

IEQ Capital's MRTX Position: Q1 2024 in Review

IEQ Capital sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 12,615 shares — an estimated $741K sold.

IEQ Capital first reported a position in MRTX in Q3 2021 and held it in 10 quarters. The position peaked at $2.27M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • IEQ Capital reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • IEQ Capital sold 12,615 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $741K.
  • IEQ Capital first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • IEQ Capital's Mirati Therapeutics, Inc. Common Stock position peaked at $2.27M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on IEQ Capital's 13F filing for Q1 2024, filed 9 May 2024.